Breaking News, Collaborations & Alliances

Cellipont, Secretome Partner for cGMP Manufacturing of STM-01 Cellular Therapy

Cellipont to provide technology transfer, analytical method transfer, and cGMP manufacturing for the STM-01 Master Cell Bank.

Author Image

By: Charlie Sternberg

Associate Editor

Cellipont Bioservices, a cell therapy Contract Development and Manufacturing Organization (CDMO), and Secretome Therapeutics, a biotechnology company advancing therapies derived from neonatal cardiac progenitor cells (nCPCs), have entered a partnership for cGMP manufacturing of Secretome Therapeutic’s lead asset STM-01. Under this partnership, Cellipont Bioservices will provide technology transfer, analytical method transfer, and cGMP manufacturing for the STM-01 Master Cell Bank. ST...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters